842252692	842252692	CD	B-NP	O
|	|	NN	I-NP	O
C	C	NN	I-NP	O
|	|	IN	B-PP	O
72771864	72771864	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3702003	3702003	CD	B-NP	O
|	|	CC	I-NP	O
7/12/2004	7/12/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Dehydration	Dehydration	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/10/2004	6/10/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/26/2004	1/26/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
KIMME	KIMME	NN	B-NP	O
,	,	,	O	O
ODELL	ODELL	NN	B-NP	O
373-40-59-0	373-40-59-0	CD	I-NP	O
Saso	Saso	NNP	I-NP	O
Downallge	Downallge	NNP	I-NP	O
As	As	IN	B-PP	O
Service	Service	NNP	B-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
4/22/04	4/22/04	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
PESTRONK	PESTRONK	NN	B-NP	O
,	,	,	O	O
VERN	VERN	NNP	B-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
CPR	CPR	NN	I-NP	B-protein
/	/	SYM	B-NP	O
No	No	NN	I-NP	O
defib	defib	NN	I-NP	O
/	/	SYM	B-NP	O
No	No	NN	I-NP	O
intubation	intubation	NN	I-NP	O
/	/	SYM	B-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/4/04	9/4/04	CD	B-NP	O
by	by	IN	B-PP	O
BLAIN	BLAIN	NN	B-NP	B-protein
,	,	,	O	O
GUILLERMO	GUILLERMO	NN	B-NP	O
P.	P.	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
29957996	29957996	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
FOLATE	FOLATE	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
FOLIC	FOLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/30	9/30	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/4/04	9/4/04	CD	B-NP	O
by	by	IN	B-PP	O
HIND	HIND	NNP	B-NP	O
,	,	,	O	O
JORGE	JORGE	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
68242397	68242397	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
THIAMINE	THIAMINE	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
MVI	MVI	NNP	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	I-protein
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/4/04	9/4/04	CD	B-NP	O
by	by	IN	B-PP	O
DEGRANGE	DEGRANGE	NN	B-NP	O
,	,	,	O	O
DIEGO	DIEGO	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
90759809	90759809	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
CREON	CREON	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
PANCRELIPASE	PANCRELIPASE	NN	I-NP	I-protein
20000U	20000U	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
4	4	CD	I-NP	O
CAPSULE	CAPSULE	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	B-protein
500	500	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/30	9/30	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
iron	iron	NN	I-NP	O
products	product	NNS	I-NP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/29/04	8/29/04	CD	B-NP	O
by	by	IN	B-PP	O
NORSETH	NORSETH	NNP	B-NP	O
,	,	,	O	O
ARMANDO	ARMANDO	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitoring	monitor	VBG	B-VP	O
LANTUS	LANTUS	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/30	9/30	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/22/04	4/22/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
not	not	RB	I-VP	O
prescribe	prescribe	VB	I-VP	O
niacin	niacin	NN	B-NP	B-protein
COUMADIN	COUMADIN	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
WARFARIN	WARFARIN	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QPM	QPM	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/22/04	4/22/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
closely	closely	RB	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Clemente	Clemente	NNP	I-NP	O
Bollozos	Bollozos	NNP	I-NP	O
-	-	:	O	O
You	You	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
contacted	contact	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
7/14/04	7/14/04	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Tedeschi	Tedeschi	NNP	I-NP	O
No	No	NNP	I-NP	O
Known	Known	NNP	I-NP	O
Allergies	Allergies	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Hyperglycemia	Hyperglycemia	NN	B-NP	O
,	,	,	O	O
dehydration	dehydration	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Dehydration	Dehydration	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
,	,	,	O	O
complete	complete	JJ	B-NP	O
heart	heart	NN	I-NP	O
block	block	NN	I-NP	O
ETOH	ETOH	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
substance	substance	NN	B-NP	O
abuse	abuse	NN	I-NP	O
S/P	S/P	NN	I-NP	O
PACER	PACER	NN	I-NP	O
PLCT	PLCT	NN	I-NP	O
1980	1980	CD	I-NP	O
H/O	H/O	NNP	I-NP	O
SILENT	SILENT	NNP	I-NP	O
IMI	IMI	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
l	l	NN	I-NP	O
nephrectomy	nephrectomy	NN	I-NP	O
s/p	s/p	NN	I-NP	O
appy	appy	JJ	I-NP	O
h/o	h/o	NN	I-NP	O
spinal	spinal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
DM	DM	NN	I-NP	O
2/2	2/2	CD	I-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ECHOCARDIOGRAM	ECHOCARDIOGRAM	NNP	I-NP	O
2/20/04	2/20/04	CD	I-NP	O
-	-	HYPH	I-NP	O
EF	EF	NN	I-NP	O
20-25	20-25	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-ADJP	O
to	to	TO	B-PP	O
severe	severe	JJ	B-NP	O
global	global	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
AI	AI	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
TV	TV	NN	B-NP	O
pacer	pacer	NN	I-NP	O
wire	wire	NN	I-NP	O
still	still	RB	B-ADVP	O
has	have	VBZ	B-VP	O
clot/veg	clot/veg	NN	B-NP	O
.	.	.	O	O

OFFICIAL	OFFICIAL	NNP	B-NP	O
READ	READ	NNP	I-NP	O
STILL	STILL	NNP	I-NP	O
PENDING	PENDING	NNP	I-NP	O
AT	AT	NNP	I-NP	O
TIME	TIME	NNP	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NNP	B-NP	O
ABDMONINAL	ABDMONINAL	NNP	I-NP	O
CT	CT	NN	I-NP	B-protein
10/26/04	10/26/04	CD	I-NP	I-protein
-	-	HYPH	O	O
No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
gall	gall	NN	B-NP	O
stones	stone	NNS	I-NP	O
,	,	,	O	O
RLL	RLL	NN	B-NP	O
inflammation	inflammation	NN	I-NP	O
?	?	.	O	O

PNA	PNA	NN	B-NP	O
,	,	,	O	O
ectatic	ectatic	JJ	B-NP	O
aorta	aorta	NN	I-NP	O
,	,	,	O	O
non-obstructing	non-obstructing	JJ	B-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
V/Q	V/Q	NN	I-NP	O
SCAN	SCAN	NN	I-NP	O
10/26/04	10/26/04	CD	I-NP	O
-	-	HYPH	I-NP	O
Low	Low	JJ	I-NP	O
probability	probability	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
66	66	CD	B-NP	O
YO	YO	NN	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
complicated	complicate	VBN	B-NP	O
PMH	PMH	NN	I-NP	O
including	include	VBG	B-PP	O
CHF	CHF	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
EF	EF	NN	I-NP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
PVD	PVD	NN	B-NP	B-protein
,	,	,	O	O
DM2	DM2	NN	B-NP	B-protein
,	,	,	O	O
CHB	CHB	NN	B-NP	B-protein
with	with	IN	B-PP	O
pacer	pacer	NN	B-NP	O
and	and	CC	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
clot	clot	NN	B-NP	O
on	on	IN	B-PP	O
pacer	pacer	NN	B-NP	O
wire	wire	NN	I-NP	O
,	,	,	O	O
non-compliant	non-compliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
medications	medication	NNS	B-NP	O
and	and	CC	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
who	who	WP	B-NP	O
developed	develop	VBD	B-VP	O
sx	sx	NN	B-NP	O
of	of	IN	B-PP	O
abd	abd	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
SOB	SOB	NN	B-NP	B-protein
with	with	IN	B-PP	O
FS	FS	NN	B-NP	O
of	of	IN	B-PP	O
500-600	500-600	CD	B-NP	O
.	.	.	O	O

PCP	PCP	NN	B-NP	O
asked	ask	VBD	B-VP	O
patient	patient	NN	B-NP	O
to	to	TO	B-VP	O
come	come	VB	I-VP	O
to	to	TO	B-VP	O
ED	ED	VBN	I-VP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
FS	FS	NN	B-NP	O
of	of	IN	B-PP	O
700	700	CD	B-NP	O
with	with	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
70s-80s	70s-80	NNS	I-NP	O
SBP	SBP	NN	I-NP	B-protein
but	but	CC	O	O
mentating	mentate	VBG	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
gap	gap	NN	I-NP	B-protein
and	and	CC	O	O
no	no	DT	B-NP	O
ketones	ketone	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
signs	sign	NNS	I-NP	O
or	or	CC	I-NP	O
sx	sx	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
with	with	IN	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

VS	VS	NNS	B-NP	O
:	:	:	O	O
99.5	99.5	CD	B-NP	O
101/62	101/62	CD	I-NP	O
70s	70s	CD	I-NP	O
SaO2	SaO2	NN	I-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
GEN	GEN	NN	B-NP	O
:	:	:	O	O
elderly	elderly	JJ	B-NP	O
ill	ill	NN	I-NP	O
appearing	appear	VBG	B-VP	O
male	male	NN	B-NP	O
in	in	IN	B-PP	O
NAD	NAD	NN	B-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
Anicteric	Anicteric	JJ	B-NP	O
sclera	sclera	NN	I-NP	O
,	,	,	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
dry	dry	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
dentition	dentition	NN	I-NP	O
NECK	NECK	NN	I-NP	O
:	:	:	O	O
Supple	Supple	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
adenopathy	adenopathy	NN	I-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	O
flat	flat	JJ	I-NP	O
CHEST	CHEST	NN	I-NP	O
:	:	:	O	O
CTA	CTA	NN	B-NP	B-protein
bilaterally	bilaterally	RB	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
with	with	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
PMI	PMI	NN	I-NP	O
,	,	,	O	O
Nl	Nl	NN	B-NP	B-protein
S1	S1	NN	I-NP	I-protein
,	,	,	O	O
S2	S2	NN	B-NP	O
S3	S3	NN	I-NP	O
present	present	JJ	I-NP	O
ABD	ABD	NN	I-NP	O
:	:	:	O	O
Reducible	Reducible	JJ	B-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
,	,	,	O	O
NT	NT	NN	B-NP	O
,	,	,	O	O
ND	ND	NN	B-NP	O
,	,	,	O	O
bowel	bowel	NN	B-NP	O
sounds	sound	VBZ	B-VP	O
present	present	JJ	B-NP	O
EXT	EXT	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
or	or	CC	I-NP	O
wounds	wound	NNS	I-NP	O
SKIN	SKIN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
rashes	rash	NNS	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
paced	pace	VBN	B-NP	O
CXR	CXR	NN	I-NP	B-protein
:	:	:	O	O
clear	clear	JJ	B-ADJP	O
with	with	IN	B-PP	O
NAD	NAD	NN	B-NP	O
ABD	ABD	NN	I-NP	O
CT	CT	NN	I-NP	O
:	:	:	O	O
small	small	JJ	B-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
,	,	,	O	O
gallstones	gallstone	NNS	B-NP	O
,	,	,	O	O
ectasia	ectasia	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
infrarenal	infrarenal	JJ	I-NP	O
aorta	aorta	NN	I-NP	O
,	,	,	O	O
RLL	RLL	NN	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
changes	change	NNS	I-NP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
PNA	PNA	NN	B-NP	B-protein
VQ	VQ	NN	I-NP	I-protein
:	:	:	O	O
Low	Low	JJ	B-NP	O
probability	probability	NN	I-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
Creatinine	Creatinine	NN	B-NP	O
of	of	IN	B-PP	O
2.2	2.2	CD	B-NP	O
that	that	WDT	B-NP	O
dropped	drop	VBD	B-VP	O
to	to	TO	B-PP	O
1.5	1.5	CD	B-NP	O
with	with	IN	B-PP	O
hydration	hydration	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
BL	BL	NN	I-NP	I-protein
1.2-1	1.2-1	CD	I-NP	I-protein
.3	.3	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

HCT	HCT	NN	B-NP	B-protein
41.6	41.6	CD	I-NP	I-protein
with	with	IN	B-PP	O
drop	drop	NN	B-NP	O
after	after	IN	B-PP	O
aggresive	aggresive	JJ	B-NP	O
hydration	hydration	NN	I-NP	O
.	.	.	O	O

Lipase	Lipase	NN	B-NP	B-protein
of	of	IN	B-PP	O
132	132	CD	B-NP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
normalizing	normalize	VBG	I-VP	O
.	.	.	O	O

UA	UA	NN	B-NP	O
and	and	CC	I-NP	O
ACE	ACE	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NNP	B-NP	O
&	&	CC	I-NP	O
PLAN	PLAN	NNP	I-NP	O
:	:	:	O	O
66	66	CD	B-NP	O
YO	YO	NN	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
complicated	complicate	VBN	B-NP	O
PMH	PMH	NN	I-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
hyperglycemia	hyperglycemia	NN	B-NP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
non-compliance	non-compliance	JJ	B-NP	O
and	and	CC	I-NP	O
hypotension	hypotension	NN	I-NP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
hypovolemia	hypovolemia	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	VBN	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
5	5	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
IVF	IVF	NN	B-NP	B-protein
and	and	CC	I-NP	O
36U	36U	NN	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
stabilized	stabilize	VBN	B-VP	O
with	with	IN	B-PP	O
volume	volume	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transfered	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

ENDOCRINE	ENDOCRINE	NN	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
DMII	DMII	NN	I-NP	I-protein
but	but	CC	B-PP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O
so	so	RB	B-ADVP	O
behaves	behave	VBZ	B-VP	O
more	more	RBR	B-PP	O
like	like	IN	I-PP	O
type	type	NN	B-NP	O
1	1	CD	I-NP	O
-	-	HYPH	O	O
needs	need	VBZ	B-VP	O
insulin	insulin	NN	B-NP	B-protein
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Per	Per	NN	B-NP	O
patient	patient	NN	I-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
QAM	QAM	NNP	I-NP	O
but	but	CC	O	O
patient	patient	NN	B-NP	O
admitted	admit	VBD	B-VP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
compliance	compliance	NN	I-NP	O
with	with	IN	B-PP	O
both	both	CC	O	O
diet	diet	NN	B-NP	O
and	and	CC	I-NP	O
insulin	insulin	NN	I-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
A1C	A1C	NN	I-NP	B-protein
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
returned	return	VBN	B-VP	O
at	at	IN	B-PP	O
19	19	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
and	and	CC	I-NP	O
Lispro	Lispro	NNP	I-NP	O
and	and	CC	O	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
ADA	ADA	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
QHS	QHS	NNP	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
requring	requre	VBG	I-VP	O
Lispro	Lispro	NNP	B-NP	O
for	for	IN	B-PP	O
FS	FS	NNP	B-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
120-600	120-600	CD	B-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
8/22	8/22	CD	B-NP	O
his	his	PRP$	B-NP	O
FS	FS	NN	I-NP	B-protein
remained	remain	VBD	B-VP	O
better	well	RBR	B-ADJP	O
controlled	control	VBN	I-ADJP	O
but	but	CC	O	O
were	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
high	high	JJ	B-ADJP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
200	200	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
400	400	CD	B-NP	I-DNA
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
3/22	3/22	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
expressed	express	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
would	would	MD	B-VP	O
like	like	VB	I-VP	O
to	to	TO	I-VP	O
leave	leave	VB	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharged	JJ	B-NP	O
o	o	NN	I-NP	O
n	n	NN	I-NP	O
Lantus	Lantus	NNP	B-NP	O
20	20	CD	I-NP	O
and	and	CC	O	O
Lispro	Lispro	NNP	B-NP	O
SS	SS	NNP	I-NP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
finger	finger	NN	B-NP	O
sticks	stick	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
ADA	ADA	NN	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
concern	concern	NN	I-NP	O
he	he	PRP	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
eating	eat	VBG	I-VP	O
sweets	sweet	NNS	B-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
own	own	JJ	I-NP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
provided	provide	VBN	B-VP	O
teaching	teaching	NN	B-NP	O
regaring	regare	VBG	B-VP	O
diet	diet	NN	B-NP	O
and	and	CC	I-NP	O
diabetes	diabetes	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
and	and	CC	O	O
lispro	lispro	NN	B-NP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
following	follow	VBG	B-PP	O
HEME	HEME	NN	B-NP	B-protein
-	-	HYPH	B-ADJP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
for	for	IN	B-PP	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
pacer	pacer	NN	B-NP	O
clot	clot	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NN	B-NP	O
shows	show	VBZ	B-VP	O
pacer	pacer	NN	B-NP	O
clot	clot	NN	I-NP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
clear	clear	JJ	B-ADJP	O
whether	whether	IN	B-SBAR	O
patient	patient	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
compliant	compliant	JJ	B-ADJP	O
enough	enough	RB	I-ADJP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
discussion	discussion	NN	B-NP	O
with	with	IN	B-PP	O
patient	patient	NN	B-NP	O
agreement	agreement	NN	I-NP	O
is	be	VBZ	B-VP	O
that	that	IN	B-SBAR	O
we	we	PRP	B-NP	O
will	will	MD	B-VP	O
d/c	d/c	VB	I-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
5	5	CD	I-NP	O
QD	QD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
INR	INR	NN	I-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
d/c	d/c	NN	B-NP	B-protein
1.2	1.2	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
with	with	IN	B-PP	O
enough	enough	JJ	B-NP	O
supply	supply	NN	I-NP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
blood	blood	NN	B-NP	O
drawn	draw	VBN	B-VP	O
by	by	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
with	with	IN	B-PP	O
results	result	NNS	B-NP	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Zarkin	Zarkin	NNP	I-NP	O
If	If	IN	B-SBAR	O
he	he	PRP	B-NP	O
his	his	PRP$	B-NP	O
not	not	RB	I-NP	O
compliant	compliant	JJ	I-ADJP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
lab	lab	NN	I-NP	O
work	work	NN	I-NP	O
the	the	DT	B-NP	O
coumadin	coumadin	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
stopped	stop	VBN	I-VP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
-	-	HYPH	I-NP	O
ISCHEMIA	ISCHEMIA	NN	I-NP	O
:	:	:	O	O
Nonobstuctive	Nonobstuctive	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
on	on	IN	B-PP	O
cath	cath	NN	B-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
episode	episode	NN	I-NP	O
.	.	.	O	O

Maintained	Maintain	VBN	B-VP	O
on	on	IN	B-PP	O
ASA	ASA	NNP	B-NP	O
,	,	,	O	O
ACEi	ACEi	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Statin	Statin	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
BB	BB	NN	I-NP	O
as	as	IN	B-PP	O
current	current	JJ	B-NP	O
cocaine	cocaine	NN	I-NP	O
user	user	NN	I-NP	O
and	and	CC	O	O
considered	consider	VBN	B-VP	O
to	to	TO	B-PP	O
dangerous	dangerous	JJ	B-NP	O
PUMP	PUMP	NN	I-NP	O
:	:	:	O	O
EF	EF	NN	B-NP	O
:	:	:	O	O
20-25	20-25	CD	B-NP	O
%	%	NN	I-NP	O
Hypovolemic	Hypovolemic	JJ	B-ADJP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
hydration	hydration	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
ACEi	ACEi	NNP	B-NP	O
for	for	IN	B-PP	O
AL	AL	NNP	B-NP	O
reduction	reduction	NN	I-NP	O
.	.	.	O	O

RHYTHM	RHYTHM	NN	B-NP	O
:	:	:	O	O
CHB	CHB	NN	B-NP	B-protein
with	with	IN	B-PP	O
PPM	PPM	NN	B-NP	B-protein
in	in	IN	B-PP	O
place	place	NN	B-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
elevated	elevated	JJ	B-NP	O
lipase	lipase	NN	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	I-NP	O
resolution	resolution	NN	I-NP	O
after	after	IN	B-PP	O
hydration	hydration	NN	B-NP	O
.	.	.	O	O

DISPO	DISPO	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
in	in	IN	B-PP	O
fair	fair	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
given	give	VBN	I-VP	O
teaching	teaching	NN	B-NP	O
regarding	regard	VBG	B-VP	O
nutrition	nutrition	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
discussed	discuss	VBN	I-VP	O
with	with	IN	B-PP	O
him	him	PRP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
agrees	agree	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
compliant	compliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
work	work	VB	I-VP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
attend	attend	VB	I-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
appointments	appointment	NNS	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
draws	draw	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
and	and	CC	O	O
Lantus	Lantus	NNP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Harnage	Harnage	NNP	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
contacted	contact	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
CODE	CODE	NN	I-NP	O
:	:	:	O	O
DNR/DNI	DNR/DNI	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
your	your	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
shot	shoot	VBD	B-VP	I-protein
-LRB-	-LRB-	RB	B-NP	I-protein
20	20	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
every	every	DT	B-NP	O
night	night	NN	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
PM	PM	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
get	get	VB	I-VP	O
your	your	PRP$	B-NP	O
dose	dose	NN	I-NP	O
for	for	IN	B-PP	O
Sunday	Sunday	NNP	B-NP	O
3/22	3/22	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
first	first	JJ	I-NP	O
dose	dose	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
Monday	Monday	NNP	B-NP	O
7/2	7/2	CD	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
PM	PM	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Visiting	Visit	VBG	B-VP	O
nursing	nursing	NN	B-NP	O
will	will	MD	B-VP	O
come	come	VB	I-VP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
home	home	NN	I-NP	O
tomorrow	tomorrow	NN	B-NP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
you	you	PRP	B-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
all	all	DT	B-NP	O
your	your	PRP$	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
important	important	JJ	I-ADJP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
checked	check	VBD	B-VP	O
regularly	regularly	RB	B-ADVP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
sure	sure	JJ	B-ADJP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
are	be	VBP	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Fair	Fair	NNP	B-NP	O
TO	TO	NNP	I-NP	O
DO/PLAN	DO/PLAN	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Take	Take	VB	B-VP	O
your	your	PRP$	B-NP	O
Lantus	Lantus	NNP	I-NP	O
every	every	DT	B-NP	O
night	night	NN	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
PM	PM	NN	I-NP	O
starting	start	VBG	B-PP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
9/6/04	9/6/04	CD	I-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
a	a	DT	B-NP	O
shot	shot	NN	I-NP	O
with	with	IN	B-PP	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
in	in	IN	B-PP	O
it	it	PRP	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Check	Check	VB	B-VP	O
your	your	PRP$	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
record	record	VB	B-VP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

Please	Please	NNP	B-NP	O
call	call	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Mattias	Mattias	NNP	I-NP	O
if	if	IN	B-SBAR	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
is	be	VBZ	B-VP	O
higher	high	JJR	B-ADJP	O
then	then	RB	B-ADVP	O
350	350	CD	B-NP	O
or	or	CC	O	O
lower	low	JJR	B-ADJP	O
then	then	RB	B-ADVP	O
50	50	CD	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Take	Take	VB	B-VP	O
all	all	DT	B-NP	O
you	you	PRP	B-NP	O
other	other	JJ	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
any	any	DT	B-NP	O
medications	medication	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
list	list	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Please	Please	NN	B-NP	B-protein
attend	attend	VBP	B-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
appointments	appointment	NNS	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
draws	draw	NNS	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
MARCUSSEN	MARCUSSEN	NNP	B-NP	O
,	,	,	O	O
WILL	WILL	NNP	B-NP	O
JAE	JAE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PA423	PA423	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4/22/04	4/22/04	CD	I-NP	O
@	@	SYM	B-NP	O
04	04	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

